Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
SHSE:688576'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 4.27 Med: 4.47 Max: 4.47
Current: 4.29
During the past 11 years, the highest Price to Peter Lynch Fair Value Ratio of Chongqing Xishan Science and Technology Co was 4.47. The lowest was 4.27. And the median was 4.47.
SHSE:688576's Price-to-Peter-Lynch-Fair-Value is ranked worse than 93.33% of 150
companies
in the Medical Devices & Instruments industry
Industry Median: 1.4
vs SHSE:688576: 4.29
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Chongqing Xishan Science and Technology Co (SHSE:688576) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 15.49 instead of 15 in this case.
Chongqing Xishan Science and Technology Co's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
40.61
/
9.46
=
4.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co Peter Lynch Fair Value Related Terms
Chongqing Xishan Science and Technology Co Peter Lynch Fair Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co Peter Lynch Fair Value Chart
Chongqing Xishan Science and Technology Co Annual Data
SHSE:688576 vs ISRG, BDX, MDLN: Peter Lynch Fair Value Comparison
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co Price-to-Peter-Lynch-Fair-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Chongqing Xishan Science and Technology Co's Price-to-Peter-Lynch-Fair-Value falls into.
Chongqing Xishan Science and Technology Co's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was ¥0.61.
* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a Peter Lynch Fair Value of ¥9.46 as of Aug. 24, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Chongqing Xishan Science and Technology Co and its competitors. According to the industry distribution chart, Chongqing Xishan Science and Technology Co ranks #140 out of 150 companies in the Medical Devices & Instruments industry, placing it in the top 93.3%.
Is Chongqing Xishan Science and Technology Co's Peter Lynch Fair Value too high?
Chongqing Xishan Science and Technology Co's current Peter Lynch Fair Value is ¥9.46. Based on the distribution chart, Chongqing Xishan Science and Technology Co ranks #140 out of 150 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's Peter Lynch Fair Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chongqing Xishan Science and Technology Co ranks #140 out of 150 companies for Peter Lynch Fair Value. This places Chongqing Xishan Science and Technology Co in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Medical Devices & Instruments company?
The median Peter Lynch Fair Value among Medical Devices & Instruments companies is 1.40, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Peter Lynch Fair Value is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current Peter Lynch Fair Value is ¥9.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥54.33, compared to a current price of ¥40.61 — trading 25.3% below its estimated fair value. The current Peter Lynch Fair Value is ¥9.46. Chongqing Xishan Science and Technology Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current Peter Lynch Fair Value is ¥9.46 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥40.61 is trading 25.3% below its estimated GF Value™ of ¥54.33.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688576:
Peter Lynch Fair Value: ¥9.46
GF Value™: ¥54.33 vs. price of ¥40.61 (25.3% below fair value)
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
88GF Score
Get the complete analysis for SHSE:688576
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
